Emerging psychoactive substances can present unusual challenges for scientists because public interest may develop faster than formal research. Before conclusions can be drawn, investigators need to understand a compound's identity, biological activity, metabolism, toxicity, and interactions. This process requires carefully collected evidence rather than assumptions based on marketing descriptions or individual experiences. 3mmc has become a subject of scientific and public-health discussion because of its stimulant properties and reported adverse effects. However, limited long-term evidence means that researchers must continue evaluating unanswered questions. Responsible articles should therefore avoid presenting uncertain information as fact and instead explain why laboratory testing, independent studies, and professional assessment are important.